Valeant Continues its Acquisition Spree with Agreement to Buy Janssen’s Ortho Dermatologics Division
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 25 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1512 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
With the aim of becoming the leading player in the fragmented dermatology market within 5 years, Valeant Pharmaceuticals has continued its deal making in this area by agreeing to acquire the assets of the Ortho Dermatologics division of Johnson & Johnson’s Janssen Pharmaceuticals for US$345 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS